证券代码：688020 证券简称：方邦股份 公告编号：2025-058 广州方邦电子股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 09 月 12 日 （二） 股东大会召开的地点：广州市黄埔区东枝路 28 号公司会议室 （五） 公司董事、监事和董事会秘书的出席情况 1、 公司在任董事8人，出席8人； 2、 公司在任监事3人，出席3人； 3、 董事会秘书王作凯先生出席了本次会议；其他高管全部列席本次会议。 二、 议案审议情况 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 41 | | --- | --- | | 普通股股东人数 | 41 | | 2、出席会议的股东所持有的表决权数量 | 38,424,009 | | 普通股股东所持有表决权数量 | 38,424,009 | ...

中国 深圳 福田区 益田路6001号太平金融大厦11、12楼 邮政编码：518038 11F/12F., Taiping Finance Tower, 6001 Yitian Road, Futian District, Shenzhen, P.R. China 518038 电话(Tel.)：(0755) 8826 5288 传真(Fax.)：(0755) 8826 5537 网址（Website）：www.sundiallawfirm.com 广东信达律师事务所 关于广州方邦电子股份有限公司 2025年第二次临时股东大会的 法律意见书 信达科会字（2025）第046号 致：广州方邦电子股份有限公司 广东信达律师事务所（以下简称"信达"）接受广州方邦电子股份有限公司（以 下简称"公司"）的委托，指派信达律师出席公司2025年第二次临时股东大会（以 下简称"本次股东大会"），对本次股东大会的合法性进行见证。 信达律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》 （以下简称"《股东会规则》"）、《律师事务所从事证券法律业务管 ...

Group 1 - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% of the company's total shares, amounting to approximately 174 million shares [1] - Jinlongyu's shareholder terminates the share transfer agreement, halting the planned transfer of 5.32% of the company's shares [1] - Doli Technology's subsidiary plans to establish a joint venture in Spain with an investment of approximately 505 million yuan, with a 70% stake held by Doli Technology [1][2] Group 2 - Chongqing Pharmaceutical, a subsidiary of Zhongyao Holdings, has received approval for clinical trials of its drug, Clopidogrel Hydrochloride Tablets [3][4] - Dongyangguang plans to jointly increase capital in a subsidiary to acquire 100% of Qinhuai Data China for 28 billion yuan [5] - Kangzhi Pharmaceutical's controlling shareholder intends to transfer 5.0004% of the company's shares at a price of 5.34 yuan per share, totaling approximately 122 million yuan [6] Group 3 - Huali Co., Ltd. announces two shareholders plan to reduce their stakes by a combined total of up to 3.96% of the company's shares [7] - Fangbang Co., Ltd.'s director plans to reduce his stake by up to 15,000 shares, representing 0.1844% of the total shares [8] - China Pacific Insurance suggests issuing HKD-denominated convertible bonds, with proceeds aimed at supporting its main insurance business and strategic initiatives [9] Group 4 - Microchip Biotech's shareholder plans to reduce its stake by up to 3% of the company's total shares [10] - Hongbai New Materials' controlling shareholder intends to reduce its stake by up to 3% due to funding needs [11] - Zhejiang Rongtai clarifies that its sales in the robotics components sector are minimal and will not significantly impact annual net profit [12] Group 5 - ST Tianmao voluntarily withdraws its application for A-share listing, which has been accepted by the Shenzhen Stock Exchange [13] - Qingxin Environment's shareholder plans to reduce its stake by up to 1% of the company's total shares [14] - Lanjik Technology's two shareholders plan to reduce their stakes by a combined total of up to 2% of the company's shares [15] Group 6 - BYD's executives and core personnel collectively increased their holdings in the company by approximately 52.33 million yuan [16] - Trina Solar's subsidiary signs contracts for the sale of 2.48 GWh of energy storage products, marking a significant overseas order [17] - Chutianlong's shareholder plans to reduce its stake by up to 3% of the company's total shares [18] Group 7 - Zhongjuxin's shareholder plans to reduce its stake by up to 2.5% of the company's total shares due to funding needs [19] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [20] - Shoukai Co., Ltd. reports a signed contract amount of 973 million yuan for August, with cumulative contracts of 13.15 billion yuan for the year [21] Group 8 - Jucheng Co., Ltd.'s shareholder plans to reduce its stake by up to 2.61% of the company's total shares due to personal funding needs [22]

Group 1: Semiconductor Equipment Manufacturers - Companies in the semiconductor equipment sector reported smooth progress in product research and market introduction, indicating a positive outlook for future developments [1] - MicroNano's ALD (Atomic Layer Deposition) equipment has achieved industrial application in high-k materials and metal compound films, with increasing production scale [1] - New Yichang has successfully validated multiple wire bonding and testing packaging equipment, receiving market recognition and bulk orders [1] Group 2: Semiconductor Testing Equipment - YaoMai Technology is advancing in semiconductor testing equipment across three levels: silicon photonic wafer testing, IC carrier board testing, and MEMS sensor testing [2] - The silicon photonic testing equipment has been continuously delivered to overseas wafer fabs, while IC carrier board testing is in the prototype system testing phase [2] - MEMS sensor testing equipment has gained recognition from leading domestic clients, with incremental orders being secured [2] Group 3: Semiconductor Materials Manufacturers - Domestic semiconductor manufacturers are rapidly enhancing competitiveness, breaking the original global industry pattern, with expansion becoming a key focus for semiconductor materials companies [3] - ShenGong Co. plans to steadily expand production capacity for silicon components, which will drive growth in large-diameter silicon materials [3] - The company anticipates that internal demand for silicon components will actively drive growth, rather than relying solely on overseas recovery [3] Group 4: Production Expansion Plans - TianCheng Technology is expanding production capacity to meet increasing orders, planning to increase the capacity of its Jinshan plant from 30,000 tons to 40,000 tons annually [4] - A new plant in Zhuhai with an annual capacity of 30,000 tons is set to begin construction soon, targeting the South China PCB market [4] - A fully-owned subsidiary in Thailand is expected to complete a 30,000-ton plant by 2026, enhancing supply capabilities in Southeast Asia [4] Group 5: Revenue Growth Expectations - Longtu Photoresist's new products from its Zhuhai plant are expected to gradually ramp up production in the second half of the year, leading to significant year-on-year revenue growth [5] - The company aims to leverage capacity release in Zhuhai as a turning point for performance recovery through high-end process breakthroughs and customer structure upgrades [5] - Fangbang Co., as an electronic materials platform enterprise, anticipates positive performance growth with the gradual ramp-up of new products such as peelable copper and flexible copper-clad laminates [5]

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

Group 1 - Hualing Steel's shareholder, Xintai Life, has recently increased its stake by 69.0862 million shares and plans to continue increasing its holdings by 1% to 2% [1] - Jingfang Technology's shareholder has terminated its share reduction plan ahead of schedule, with no shares sold during the period [1] - Huali Co., Ltd. plans to reduce its holdings by no more than 3.96% of the company's shares [1] Group 2 - Various companies, including Wuchan Jinlun, Changhua Chemical, COFCO Technology, and Jieshun Technology, have announced plans to reduce their holdings by no more than 3% of their shares [1] - Other companies such as Micron Biotech, Hongbai New Materials, and Jucheng Technology have also indicated plans to reduce their stakes by varying percentages, mostly around 2% to 3% [1] - Specific reductions include 2.61% by Jucheng Co., 2.5% by Zhongju Xinxin, and 1.94% by Jiahe Meikang [1]

截至发稿，方邦股份市值为49亿元。 每经头条（nbdtoutiao）——"史上最丑"与"丑上最薄"：iPhone 17系列背后的新战事 （记者 王晓波） 每经AI快讯，方邦股份（SH 688020，收盘价：60.64元）9月10日晚间发布公告称，截至本公告披露 日，广州方邦电子股份有限公司董事叶勇先生直接持有公司股份约60万股，占公司总股本的0.74%。股 份来源于IPO 前取得的股份，并于2020年7月22日起上市流通。 因个人资金需求，叶勇先生计划自本公告披露之日起15个交易日后的3个月内，通过集中竞价交易或大 宗交易方式减持股份数量不超过15万股，占公司总股本比例不超过0.1844%，减持股份总数占其本次减 持前所持有公司股份总数的比例不超过25%。若计划减持期间出现送股、资本公积金转增股本、配股等 除权除息事项，减持股份数量将相应进行调整。 2024年1至12月份，方邦股份的营业收入构成为：电子专用材料制造占比89.09%，其他业务占比 10.91%。 ...

方邦股份(688020.SH)发布公告，因个人资金需求，董事叶勇计划自公告披露之日起15个交易日后的3个 月内，通过集中竞价交易或大宗交易方式减持股份数量不超过15万股，占公司总股本比例不超过 0.1844%，减持股份总数占其本次减持前所持有公司股份总数的比例不超过25%。 ...

方邦股份(688020.SH)发布公告，因个人资金需求，董事叶勇计划自公告披露之日起15个交易日后的3个 月内，通过集中竞价交易或大宗交易方式减持股份数量不超过15万股，占公司总股本比例不超过 0.1844%，减持股份总数占其本次减持前所持有公司股份总数的比例不超过25%。 ...

证券代码：688020 证券简称：方邦股份 公告编号：2025-056 广州方邦电子股份有限公司 董事减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 截至本公告披露日，广州方邦电子股份有限公司（以下简称"公司"）董 事叶勇先生直接持有公司股份 604,018 股，占公司总股本的 0.74%。股份来源于 IPO 前取得的股份，并于 2020 年 7 月 22 日起上市流通。 因个人资金需求，叶勇先生计划自本公告披露之日起 15 个交易日后的 3 个月内，通过集中竞价交易或大宗交易方式减持股份数量不超过 150,000 股，占 公司总股本比例不超过 0.1844%，减持股份总数占其本次减持前所持有公司股份 总数的比例不超过 25%。若计划减持期间出现送股、资本公积金转增股本、配股 等除权除息事项，减持股份数量将相应进行调整。 | 股东名称 | 叶勇 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | √否 | ...